Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00491400 · ClinicalTrials.gov registry record · NA
Effect of a Fibrate and a Statin on Endothelial Dysfunction
A NA study, sponsored by Boston University.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT00491400 is a NA study that was terminated before completion, run by Boston University. The registered enrollment target is 28 participants.
The verdict
NCT00491400, a NA study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The study will compare the effect of atorvastatin to the effect of fenofibrate on endothelial function in patients with diabetes mellitus or the metabolic syndrome.
Interventions
- DRUG Fenofibrate
- DRUG Atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00491400
The ClinicalTrials.gov registry entry for NCT00491400 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fenofibrate is the first listed.
NCT00491400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00491400 about?
NCT00491400 is a clinical study titled "Effect of a Fibrate and a Statin on Endothelial Dysfunction". The study will compare the effect of atorvastatin to the effect of fenofibrate on endothelial function in patients with diabetes mellitus or the metabolic syndrome.
What is the current status of trial NCT00491400?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2005-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00491400?
The interventions under investigation include: Fenofibrate (DRUG), Atorvastatin (DRUG).
Who is sponsoring clinical trial NCT00491400?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.